ask="2.77"
ask_size="100"
average_daily_volume="837792"
bid="2.55"
bid_size="200"
book_value="0.34"
change="-1.17"
change_from_200_day_moving_average="0.85"
change_from_50_day_moving_average="0.83"
change_from_52_week_high="-2.57"
change_From_52_week_low="1.42"
change_in_percent="-31.62%"
close="2.53"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.49"
ebitda="-12.32M"
eps_estimate_current_year="-1.58"
eps_estimate_next_quarter="-0.36"
eps_estimate_next_year="-0.88"
ex_dividend_date="N/A"
float_shares="4192000"
high="3.38"
high_52_weeks="5.10"
last_trade_date="2/22/2017"
last_trade_price="2.53"
last_trade_size="2136"
last_trade_time="4:00pm"
low="2.50"
low_52_weeks="1.11"
market_capitalization="24.25M"
moving_average_200_day="1.68"
moving_average_50_day="1.70"
name="Eyegate Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="10.00"
open="3.29"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+51.01%"
percent_change_from_50_day_moving_average="+48.94%"
percent_change_from_52_week_high="-50.39%"
percent_change_from_52_week_low="+127.93%"
previous_close="3.70"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="10.91"
price_per_sales="69.69"
revenue="508889.00"
shares_outstanding="9585000"
short_ratio="0.76"
stock_exchange="NCM"
symbol="EYEG"
volume="5571023"
weeks_range_52="1.11 - 5.10"
